Xencor reported $329.63M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Arrowhead Research ARWR:US $ 384.6M 141.36M
AstraZeneca AZN:LN 26.69B 583M
Biogen BIIB:US $ 7162.3M 21.4M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Cytokinetics CYTK:US $ 494.94M 130.71M
Epizyme EPZM:US $ 247.6M 24.89M
GlaxoSmithKline GSK:LN 18.25B 688M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Macrogenics MGNX:US $ 334.7M 32.3M
Novartis NOVN:VX 26.25B 2.45B
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Xencor XNCR:US $ 329.63M 151.34M